Some of the core issues of $GLOBALFOUNDRIES Inc.(GFS)$profitability in the past are largely due to its strong focus on manufacturing in US while starving its Asia plants from large orders. With new indications of refocus into Asia such as its $4 billion investment to its largest plant in Singapore (shorturl.at/ikBWX, tentatively operational in early 2023), its outlook seems promising. Every foundry that has plant in Taiwan and Singapore are profitable. Siltronics just announced investment into expansion in Singapore too.At right price, GFS is definitely a growth stockto invest for mid-term.
Countries with high vaccination rates and already started booster shots will likelihood continue with existing list of vaccines and will be low volume procurement just to satisfy those low % of people holding back from mRNA ones. Countries with low vaccination rates may explore alternative vaccine(s) if price is significantly cheaper. Overall, not expecting to sell in high volumes unlike mRNA ones where additional procurement to cater for booster shots already locked in or in the mist of it.
Corrections have not even really begin for most super overvalued stocks… Perhaps time will tell if it turns out a part of history where those younger investors who have never experienced the 2008/9, 2011/2, 2018 downturns will take a lesson or two.
Why September Shouldn't Make You Panic About the Stock Market
A few lesser known/reported expansions are still ongoing and likelihood to complete around December. Once those capacity expansions complete, there will be more room for growth. Right now moving side-ways is largely due to capacity limitation (already max out).
TSMC revenue for September was approximately NT$152.69 billion,an increase of 19.7% YOY
Despite price increases on its products just a month or two ago, the earnings is only 18%, kind of low side. Shouldn’t the stock price movedownwards instead?
TSMC’s November sales were 148.27 billion Taiwan dollars, an increase of 18.7% year-on-year.